193 related articles for article (PubMed ID: 29147378)
1. Male Breast Cancer and Hyperestrogenemia: A Thirteen-Year Review.
Tariq KB; Al-Saffar F; Ibrahim S; Pham D; Farhangi A; Rana F; Zaiden R
World J Oncol; 2014 Apr; 5(2):55-61. PubMed ID: 29147378
[TBL] [Abstract][Full Text] [Related]
2. TNBC vs. Non-TNBC: A Five-Year Retrospective Review of Differences in Mean Age, Family History, Smoking History and Stage at Diagnosis at an Inner City University Program.
Tariq K; Rana F
World J Oncol; 2013 Dec; 4(6):241-247. PubMed ID: 29147364
[TBL] [Abstract][Full Text] [Related]
3. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
[TBL] [Abstract][Full Text] [Related]
9. Hormone receptor-positive breast cancer and black race: does sex matter?
Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
[TBL] [Abstract][Full Text] [Related]
10. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
11. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
Aggarwal A; Adepoju B; Yacur M; Maron D; Sharma MC
Clin Breast Cancer; 2021 Aug; 21(4):e471-e478. PubMed ID: 33619003
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
13. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and risk factors for recurrence in mucinous breast cancer].
Lei L; Chen ZZ; Zheng YB; Chen B; Wang X; Wang XJ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):274-279. PubMed ID: 28550667
[No Abstract] [Full Text] [Related]
15. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
[TBL] [Abstract][Full Text] [Related]
16. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
17. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in Pakistani Population: A 10-Year Retrospective Cross-Sectional Study.
Khalid IB; Sarwar A; Khalid HB; Sajjad B; Rehman B; Parvaiz MA
Breast Cancer (Auckl); 2024; 18():11782234241233120. PubMed ID: 38370290
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of male triple negative breast cancer: A population-based study.
Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]